A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
Clinical trial NCT02521844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02521844
- Sponsor
- EDDC (Experimental Drug Development Centre), A*STAR Research Entities
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2024-10-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.